Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway
By: Qing Su, Baolin Xu, Zhoubin Tian and Ziling Gong
Download Article
Download the full article as a PDF file.
Language: English
Page range: 389 - 402
Accepted on: Dec 14, 2021
Published on: Apr 13, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2022 Qing Su, Baolin Xu, Zhoubin Tian, Ziling Gong, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.